ATF3
Chelidonium majus
SKOV3
Tip60
apoptosis
ovarian cancer
Journal
Journal of microbiology and biotechnology
ISSN: 1738-8872
Titre abrégé: J Microbiol Biotechnol
Pays: Korea (South)
ID NLM: 9431852
Informations de publication
Date de publication:
28 Apr 2022
28 Apr 2022
Historique:
received:
15
09
2021
revised:
16
01
2022
accepted:
14
02
2022
pubmed:
15
3
2022
medline:
4
5
2022
entrez:
14
3
2022
Statut:
ppublish
Résumé
Forkhead transcription factor 3a (Foxo3a) is believed to be a tumor suppressor as its inactivation leads to cell transformation and tumor development. However, further investigation is required regarding the involvement of the activating transcription factor 3 (ATF3)-mediated Tat-interactive protein 60 (Tip60)/Foxo3a pathway in cancer cell apoptosis. This study demonstrated that
Identifiants
pubmed: 35283423
pii: jmb.2109.09030
doi: 10.4014/jmb.2109.09030
pmc: PMC9628819
doi:
Substances chimiques
ATF3 protein, human
0
Activating Transcription Factor 3
0
FOXO3 protein, human
0
Forkhead Box Protein O3
0
Forkhead Transcription Factors
0
Gene Products, tat
0
RNA, Small Interfering
0
bcl-2-Associated X Protein
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
493-503Références
Oncogene. 2008 Apr 3;27(15):2118-27
pubmed: 17952119
Mol Cell. 2006 Dec 28;24(6):827-39
pubmed: 17189186
Phytomedicine. 2015 Dec 15;22(14):1279-87
pubmed: 26626193
Eur J Cell Biol. 2001 Jan;80(1):111-8
pubmed: 11211931
Mol Cell Biol. 2004 Oct;24(19):8681-90
pubmed: 15367686
Anticancer Res. 2016 Feb;36(2):509-16
pubmed: 26851004
Forsch Komplementmed. 2010 Oct;17(5):241-8
pubmed: 20980763
Phytomedicine. 2013 Feb 15;20(3-4):282-94
pubmed: 23238299
Arch Pathol Lab Med. 2009 Nov;133(11):1775-81
pubmed: 19886711
Cell Cycle. 2012 Jul 15;11(14):2660-71
pubmed: 22732497
Cent Eur J Immunol. 2015;40(4):400-10
pubmed: 26862303
J Biol Chem. 1996 Jan 19;271(3):1695-701
pubmed: 8576171
Biochim Biophys Acta. 2011 Nov;1813(11):1978-86
pubmed: 21440011
Talanta. 2012 Sep 15;99:932-8
pubmed: 22967645
J Ethnopharmacol. 2002 Sep;82(1):51-3
pubmed: 12169406
Evid Based Complement Alternat Med. 2012;2012:485042
pubmed: 22988474
Oncol Rep. 2015 Apr;33(4):1837-43
pubmed: 25634491
Gene. 2001 Jul 25;273(1):1-11
pubmed: 11483355
Front Oncol. 2013 Jun 05;3:149
pubmed: 23761862
Aging (Albany NY). 2019 Jun 14;11(11):3731-3749
pubmed: 31199782
J Biol Chem. 2012 May 18;287(21):17737-17745
pubmed: 22474286
J Ethnopharmacol. 2016 Aug 22;190:362-71
pubmed: 27350008
Epigenomics. 2015;7(8):1351-63
pubmed: 26638912
J Cell Sci. 2007 Aug 1;120(Pt 15):2479-87
pubmed: 17646672
J Ethnopharmacol. 2007 May 30;112(1):40-8
pubmed: 17353105
BMC Syst Biol. 2018 Mar 19;12(Suppl 2):20
pubmed: 29560827
Carcinogenesis. 2014 Feb;35(2):452-60
pubmed: 24067903
Phytomedicine. 2016 Mar 15;23(3):253-66
pubmed: 26969379
Food Sci Nutr. 2018 Oct 25;6(8):2395-2401
pubmed: 30510740
Int J Clin Exp Pathol. 2017 Nov 01;10(11):11069-11074
pubmed: 31966454
Oncotarget. 2015 Dec 1;6(38):41290-306
pubmed: 26512777
Cell Death Dis. 2015 Aug 20;6:e1857
pubmed: 26291311
Pharmacol Res. 1996 Feb;33(2):127-34
pubmed: 8870028
Oncology. 2005;68(4-6):293-8
pubmed: 16020955
Int J Womens Health. 2019 Apr 30;11:287-299
pubmed: 31118829
Pharmacol Res. 2020 Sep;159:104934
pubmed: 32464330
World J Gastroenterol. 2009 Aug 7;15(29):3603-10
pubmed: 19653337
J Natl Cancer Inst. 1984 Mar;72(3):513-21
pubmed: 6583437
J Mol Med (Berl). 2009 Nov;87(11):1053-60
pubmed: 19705082
Mol Med Rep. 2015 Aug;12(2):2161-8
pubmed: 25890994
Oncogene. 2009 Mar 26;28(12):1506-17
pubmed: 19169279
Adv Exp Med Biol. 2009;665:242-60
pubmed: 20429429
Biochim Biophys Acta Gen Subj. 2017 Aug;1861(8):2020-2030
pubmed: 28479277
Cell Death Differ. 2016 Jul;23(7):1198-208
pubmed: 26915295
Anal Cell Pathol (Amst). 2017;2017:8158254
pubmed: 28702312
J Biol Chem. 2008 Oct 31;283(44):29795-801
pubmed: 18755691
Mo Med. 2005 May-Jun;102(3):236-9
pubmed: 15960048
Eur J Pharmacol. 2012 Jul 5;686(1-3):1-7
pubmed: 22503932
Chem Biol Interact. 2014 Nov 5;223:141-9
pubmed: 25265580
Cancer Cell Int. 2015 Jan 24;15(1):1
pubmed: 25678856
J Ovarian Res. 2019 Apr 30;12(1):38
pubmed: 31039796
Biomed Pharmacother. 2021 Jun;138:111536
pubmed: 34311534
Oncotarget. 2014 Sep 30;5(18):8569-82
pubmed: 25149542
Oncoimmunology. 2014 Dec 21;3(11):e970025
pubmed: 25941598
Oncol Lett. 2018 Sep;16(3):3108-3116
pubmed: 30127902
Cell Death Dis. 2016 Feb 25;7:e2111
pubmed: 26913603
Mol Cell Oncol. 2015 Feb 03;3(1):e1010948
pubmed: 27308526
Cancer Res. 2006 Jan 1;66(1):212-20
pubmed: 16397234
Mol Cancer Ther. 2008 Oct;7(10):3237-46
pubmed: 18852127